Showing results 1 to 3 of 3
Title | Author(s) | Issue Date | |
---|---|---|---|
HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study Proceeding/Conference:Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
12-Jan-2023 | |||
2015 |